Mealey's (February 10, 2023, 9:03 AM EST) -- CAMDEN, N.J. — A New Jersey federal court judge presiding over the valsartan/losartan/irbesartan hypertension drugs multidistrict litigation on Feb. 8 granted qualified approval of plaintiff motions to certify classes and subclasses of plaintiffs and denied without prejudice certification of a fourth class....